BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Biogipuzkoa - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://bio-gipuzkoa.eus/en/
X-WR-CALDESC:Events for Biogipuzkoa
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20260527T130000
DTEND;TZID=Europe/Madrid:20260527T140000
DTSTAMP:20260525T050018
CREATED:20260514T110058Z
LAST-MODIFIED:20260514T110058Z
UID:105991-1779886800-1779890400@bio-gipuzkoa.eus
SUMMARY:Smart RNA Delivery to Treat Eye Disease
DESCRIPTION:Dr. Leblond has been a senior researcher at INSERM since 2019 and heads the ARNA Lab\, where she leads the Targeted Aptamers\, Medicines and Sensing group. Her background combines a strong foundation in chemistry with extensive experience in pharmaceutical sciences\, focused on the development of advanced drug and gene delivery systems.\nHer research focuses on the design of intelligent therapeutic delivery systems using lipid nanoparticles—similar to those used in mRNA vaccines—and aptamers\, DNA or RNA sequences capable of recognizing specific targets in the body with high affinity and selectivity.\nBefore joining ARNA\, she was an associate professor at the University of Montreal\, where she developed pH-sensitive lipid nanoparticles for the efficient intracellular delivery of drugs and genetic material\, one of the major current challenges in nanomedicine.\nCurrently\, her group is working on the development of multifunctional nanocarriers that integrate molecular design\, physicochemical characterization\, and biological evaluation\, with the aim of advancing toward clinical applications. This is an excellent opportunity to learn firsthand about cutting-edge advances in nanomedicine and RNA-based therapies.
URL:https://bio-gipuzkoa.eus/en/agenda/smart-rna-delivery-to-treat-eye-disease/
LOCATION:Salón de Actos\, IIS Biogipuzkoa\, Paseo Dr. Begiristain\, s/n\, SAN SEBASTIÁN\, Gipuzkoa\, 20014\, Spain
CATEGORIES:Agenda,Formation,Seminars
ATTACH;FMTTYPE=image/jpeg:https://bio-gipuzkoa.eus/wp-content/uploads/2026/05/Jeanne-Leblond-.jpg
END:VEVENT
END:VCALENDAR